Local BCG failures in superficial bladder cancer. A multivariate analysis of risk factors influencing survival Academic Article uri icon

Overview

MeSH Major

  • BCG Vaccine
  • Urinary Bladder Neoplasms

abstract

  • Of 221 patients with superficial bladder cancers treated with intravesical BCG, BCG therapy failed locally within the bladder or prostate in 41 patients. A multivariate analysis was done using data on these local failures to identify clinical variables influencing survival. Patients presenting with T1 tumors which relapsed initially in the prostate were at highest risk of dying of bladder cancer. Cystectomy is justified in such patients. Others with noninvasive local refractory disease can be managed by continued conservative therapy.

publication date

  • January 1991

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 2022226

Additional Document Info

start page

  • 97

end page

  • 100

volume

  • 19

number

  • 2